Synopsys stock rises in premarket as traders seek stability

2 min read     Updated on 20 Jul 2026, 04:12 PM
scanx
Reviewed by
Shriram SScanX News Team
AI Summary

Synopsys Inc shares are trading higher in the premarket session as traders seek stability following a recent drawdown. The stock remains technically weak, trading below its 20-day, 50-day, 100-day, and 200-day simple moving averages, with an RSI indicating oversold conditions. Analysts remain bullish, with a Buy rating and an average price target of $559.50, while the company prepares for its estimated earnings report on September 8, 2026.

powered bylight_fuzz_icon
45849996

*this image is generated using AI for illustrative purposes only.

Synopsys Inc shares are trading slightly higher during Monday’s premarket session as traders lean into a firmer overnight tone and look for stabilization after a steep multi-month drawdown. Nasdaq futures are up 0.41% while S&P 500 futures have gained 0.21%. The early lift looks more like a broad risk-on bid in premarket futures than a stock-specific breakout, with SNPS trying to base near the lower end of its 52-week range. Synopsys shares were up 0.20% at $385.06 during premarket trading on Monday.

Critical Technical Levels To Watch For SNPS

From a trend perspective, the stock is still in a clear downtrend: it’s trading 11.9% below its 20-day SMA, 17.5% below its 50-day SMA, and about 14% below both its 100-day and 200-day SMAs. That cluster of moving averages overhead is the main "supply zone" bulls need to reclaim before the chart starts to look healthier. RSI is the key momentum indicator right now, sitting at 22.93, which signals the selloff has become stretched, and the stock is in oversold territory.

Metric Value
Key Resistance $442.00 (near 20-day SMA of $441.42)
Key Support $388.00 (near current price)
RSI 22.93
20-day SMA $441.42
50-day SMA Not specified
100-day SMA Not specified
200-day SMA Not specified

The crossover picture is mixed: the 20-day SMA below the 50-day SMA keeps near-term pressure intact, but the golden cross from June (50-day above 200-day) is a reminder the longer-term trend only recently rolled over.

Synopsys (SNPS) Earnings Preview for September 2026

Looking further out, the next major catalyst for the stock arrives with the September 8, 2026 (estimated) earnings report.

  • EPS Estimate: $3.47 (Up from $3.39 YoY)
  • Revenue Estimate: $2.44 Billion (Up from $1.74 Billion YoY)
  • Valuation: P/E of 87.9x

The stock carries a Buy rating with an average price target of $559.50 (19 analysts). Recent analyst moves include Benchmark initiating with a Buy (Target $570.00) on July 16, Piper Sandler upgrading to Overweight (Target $550.00) on June 23, and Citigroup maintaining a Buy (Target $610.00) on May 28.

Synopsys (SNPS) Benzinga Edge Rankings Breakdown

Below is the Benzinga Edge scorecard for Synopsys, highlighting its strengths and weaknesses compared to the broader market:

  • Momentum: Weak (Score: 7.91)
  • Quality: Neutral (Score: 43.56)
  • Value: Weak (Score: 8.52)
  • Growth: Weak (Score: 6.28)

Synopsys’s Benzinga Edge signal reveals a weak, valuation-heavy setup where the chart is doing most of the talking right now. For longer-term bulls, the key is whether an oversold bounce can turn into a base and reclaim the $442.00 area.

Top ETF Exposure for Synopsys (SNPS) Stock

  • VanEck Fabless Semiconductor ETF (NASDAQ: SMHX): 4.23% Weight
  • Alger Mid Cap 40 ETF (NYSE: FRTY): 3.40% Weight
  • ERShares Entrepreneurs ETF (NASDAQ: ENTR): 3.66% Weight

Because SNPS carries significant weight in these funds, any significant inflows or outflows for these ETFs will likely force automatic buying or selling of the stock.

Will the current oversold RSI levels trigger a sustained bounce, or is further downside likely before the stock stabilizes?

How might the high P/E ratio of 87.9x impact investor sentiment if earnings growth slows in the coming quarters?

What catalysts, aside from the September 2026 earnings report, could help SNPS reclaim the $442 resistance level?

like20
dislike

Benchmark initiates coverage on Synopsys with Buy rating

0 min read     Updated on 16 Jul 2026, 04:47 PM
scanx
Reviewed by
Radhika SScanX News Team
AI Summary

Benchmark analyst Gary Mobley initiated coverage on Synopsys with a Buy rating and a price target of $570, signaling a positive outlook for the stock.

powered bylight_fuzz_icon
45746204

*this image is generated using AI for illustrative purposes only.

Benchmark analyst Gary Mobley has initiated coverage on Synopsys with a Buy rating and announced a price target of $570. The rating highlights a positive outlook for the company's stock performance.

Analyst Details

The coverage initiation comes from Gary Mobley, an analyst at Benchmark. The Buy rating suggests that the stock is expected to outperform the market.

Price Target

Mobley set a price target of $570 for Synopsys. This target indicates the analyst's projection for the stock's future value.

What specific factors drove Gary Mobley's decision to initiate coverage with a Buy rating?

How does Synopsys' current market position support the projected price target of $570?

What are the potential risks or challenges that could hinder Synopsys from reaching this price target?

like20
dislike

More News on Synopsys Inc